Jamshid MaddahiDirector, Professor | Los Angeles, California
Dr. Jamshid Maddahi is internationally recognized as a leader and expert in cardiovascular disease research, teaching and patient care. Dr. Maddahi obtained his MD degree with Distinguished Honors in 1975 from Tehran University. He subsequently completed his residency and fellowship training in the United States in Internal Medicine, Cardiovascular Diseases, Nuclear Medicine, and Nuclear cardiology. Dr. Maddahi began his academic and research career in 1977 in the field of Nuclear Cardiology. His pioneering and collaborative research in this field has led to several seminal articles on clinical applications of Nuclear Cardiology. The scope of his research has included development and validation of methods for assessment of myocardial perfusion, detection and risk stratification of patients with suspected or known coronary artery disease, assessment of myocardial viability and cost effectiveness of nuclear imaging in the management of patients. At the present, Nuclear Cardiology has become a standard technique in cardiology. In the US alone, more than 10 million Nuclear Cardiology procedures are done each year. In 1990, Dr. Maddahi became Director of Clinical PET Center at UCLA with the overall goal of extending applications of the new technique of PET scanning into the clinical arena in oncology, cardiology and neurology. Over the ensuing years, the pioneering work of the UCLA team led to ever increasing role of the PET scanning technique in management of patients with cancer and heart disease. In 1998, Dr. Maddahi extended his research interest to the field of Cardiac CT. In 2007.
Dr. Maddahi lead the clinical investigations on the use of a new F-18 labeled PET perfusion agent. This tracer, that is currently in Pahse II clinical trials, has the potential of becoming the dominant tracer for noninvasive assessment of coronary artery disease. Dr. Maddahi became Assistant Professor of Medicine at UCLA in 1981 and is currently Clinical Professor (level 6) of Molecular and Medical Pharmacology (Nuclear Medicine) and Medicine (Cardiology) at David Geffen School of Medicine at UCLA. He is also Director of Biomedical Imaging Institute. The initiative of this institute has been to elevate the quality of cardiac imaging centers in the community. During his academic career, Dr. Maddahi has received several million Dollars of research funding from the National Institute of Health and non governmental sources. He has authored more than 200 original research articles,